Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Calcified Tissue International|August 1, 1991
Seasonal variation in bone metabolism in young healthy subjectsD Vanderschueren, G Gevers, J Dequeker, et al.
Journal of Hepatology|August 19, 2022
Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitisRomée J A L M Snijders, Tom J G Gevers, Michael A Heneghan, et al.
Journal of Hepatology|March 19, 2013
Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trialMelissa Chrispijn, Tom J G Gevers, Jeroen C Hol, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 24, 2023
Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapyThijs R M Barten, Christian B Staring, Marie C Hogan, et al.
Therapeutic Advances in Gastroenterology|October 11, 2018
Drug holiday in patients with polycystic liver disease treated with somatostatin analoguesRené M M van Aerts, Marieke Kolkman, Wietske Kievit, et al.
European Radiology|December 14, 2018
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cystsMyrte K Neijenhuis, Titus F M Wijnands, Wietske Kievit, et al.
Gastro Hep Advances|June 15, 2026
Quality of Evidence in Remote Monitoring of Patients With Liver Cirrhosis: A Systematic ReviewBritt van Ruijven, Marten A Lantinga, Joost P H Drenth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 5, 2014
Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trialTom J G Gevers, Jeroen C Hol, René Monshouwer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 1, 1988
Staging and follow-up of rheumatoid arthritis of the knee. Comparison of sonography, thermography, and clinical assessmentM van Holsbeeck, K van Holsbeeck, G Gevers, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2015
Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trialsM K Neijenhuis, T J G Gevers, F Nevens, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Calcified Tissue International|August 1, 1991
Seasonal variation in bone metabolism in young healthy subjectsD Vanderschueren, G Gevers, J Dequeker, et al.
Journal of Hepatology|August 19, 2022
Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitisRomée J A L M Snijders, Tom J G Gevers, Michael A Heneghan, et al.
Journal of Hepatology|March 19, 2013
Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trialMelissa Chrispijn, Tom J G Gevers, Jeroen C Hol, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 24, 2023
Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapyThijs R M Barten, Christian B Staring, Marie C Hogan, et al.
Therapeutic Advances in Gastroenterology|October 11, 2018
Drug holiday in patients with polycystic liver disease treated with somatostatin analoguesRené M M van Aerts, Marieke Kolkman, Wietske Kievit, et al.
European Radiology|December 14, 2018
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cystsMyrte K Neijenhuis, Titus F M Wijnands, Wietske Kievit, et al.
Gastro Hep Advances|June 15, 2026
Quality of Evidence in Remote Monitoring of Patients With Liver Cirrhosis: A Systematic ReviewBritt van Ruijven, Marten A Lantinga, Joost P H Drenth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 5, 2014
Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trialTom J G Gevers, Jeroen C Hol, René Monshouwer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 1, 1988
Staging and follow-up of rheumatoid arthritis of the knee. Comparison of sonography, thermography, and clinical assessmentM van Holsbeeck, K van Holsbeeck, G Gevers, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2015
Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trialsM K Neijenhuis, T J G Gevers, F Nevens, et al.
Pageof 10